276 related articles for article (PubMed ID: 29439951)
1. Enhancer dysfunction in leukemia.
Bhagwat AS; Lu B; Vakoc CR
Blood; 2018 Apr; 131(16):1795-1804. PubMed ID: 29439951
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulators form diverse groups with context-dependent regulatory functions.
Stampfel G; Kazmar T; Frank O; Wienerroither S; Reiter F; Stark A
Nature; 2015 Dec; 528(7580):147-51. PubMed ID: 26550828
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of Hoxa9 binding sites in hematopoietic cells.
Huang Y; Sitwala K; Bronstein J; Sanders D; Dandekar M; Collins C; Robertson G; MacDonald J; Cezard T; Bilenky M; Thiessen N; Zhao Y; Zeng T; Hirst M; Hero A; Jones S; Hess JL
Blood; 2012 Jan; 119(2):388-98. PubMed ID: 22072553
[TBL] [Abstract][Full Text] [Related]
4. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
[TBL] [Abstract][Full Text] [Related]
5. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
[TBL] [Abstract][Full Text] [Related]
6. Trimeric association of Hox and TALE homeodomain proteins mediates Hoxb2 hindbrain enhancer activity.
Jacobs Y; Schnabel CA; Cleary ML
Mol Cell Biol; 1999 Jul; 19(7):5134-42. PubMed ID: 10373562
[TBL] [Abstract][Full Text] [Related]
7. Cellular signaling and epigenetic regulation of gene expression in leukemia.
Gowda C; Song C; Ding Y; Iyer S; Dhanyamraju PK; McGrath M; Bamme Y; Soliman M; Kane S; Payne JL; Dovat S
Adv Biol Regul; 2020 Jan; 75():100665. PubMed ID: 31623972
[TBL] [Abstract][Full Text] [Related]
8. Alterations of lymphoid enhancer factor-1 isoform expression in solid tumors and acute leukemias.
Wang W; Ji P; Steffen B; Metzger R; Schneider PM; Halfter H; Schrader M; Berdel WE; Serve H; Müller-Tidow C
Acta Biochim Biophys Sin (Shanghai); 2005 Mar; 37(3):173-80. PubMed ID: 15756419
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
Collins CT; Hess JL
Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
[TBL] [Abstract][Full Text] [Related]
10. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
San-Marina S; Han Y; Liu J; Minden MD
Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
[TBL] [Abstract][Full Text] [Related]
11. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
[TBL] [Abstract][Full Text] [Related]
12. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MYB by distal enhancer elements in human myeloid leukemia.
Li M; Jiang P; Cheng K; Zhang Z; Lan S; Li X; Zhao L; Wang Y; Wang X; Chen J; Ji T; Han B; Zhang J
Cell Death Dis; 2021 Feb; 12(2):223. PubMed ID: 33637692
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2.
Li FQ; Person RE; Takemaru K; Williams K; Meade-White K; Ozsahin AH; Güngör T; Moon RT; Horwitz M
J Biol Chem; 2004 Jan; 279(4):2873-84. PubMed ID: 14594802
[TBL] [Abstract][Full Text] [Related]
15. Enhancer Features that Drive Formation of Transcriptional Condensates.
Shrinivas K; Sabari BR; Coffey EL; Klein IA; Boija A; Zamudio AV; Schuijers J; Hannett NM; Sharp PA; Young RA; Chakraborty AK
Mol Cell; 2019 Aug; 75(3):549-561.e7. PubMed ID: 31398323
[TBL] [Abstract][Full Text] [Related]
16. Transcription enhancer factor-1 (TEF-1) DNA binding sites can specifically enhance gene expression at the beginning of mouse development.
Mélin F; Miranda M; Montreau N; DePamphilis ML; Blangy D
EMBO J; 1993 Dec; 12(12):4657-66. PubMed ID: 8223475
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
18. Combinatorial function of transcription factors and cofactors.
Reiter F; Wienerroither S; Stark A
Curr Opin Genet Dev; 2017 Apr; 43():73-81. PubMed ID: 28110180
[TBL] [Abstract][Full Text] [Related]
19. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
Meyers S; Lenny N; Sun W; Hiebert SW
Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
[TBL] [Abstract][Full Text] [Related]
20. Promoter/enhancer-based controllability of regulatory networks.
Devkota P; Wuchty S
Sci Rep; 2022 Mar; 12(1):3528. PubMed ID: 35241702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
